Cargando…

A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis

It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of...

Descripción completa

Detalles Bibliográficos
Autor principal: Langley, Paul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401380/
https://www.ncbi.nlm.nih.gov/pubmed/36033108
http://dx.doi.org/10.24926/iip.v12i4.4329
_version_ 1784772956379938816
author Langley, Paul C.
author_facet Langley, Paul C.
author_sort Langley, Paul C.
collection PubMed
description It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of health technology assessment is called into question due to a failure to recognize the well-documented limitations imposed by the axioms of fundamental measurement. The purpose of this commentary is provide a critical examination of this practice in recommendations for atopic dermatitis.
format Online
Article
Text
id pubmed-9401380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-94013802022-08-25 A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis Langley, Paul C. Innov Pharm Commentary It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of health technology assessment is called into question due to a failure to recognize the well-documented limitations imposed by the axioms of fundamental measurement. The purpose of this commentary is provide a critical examination of this practice in recommendations for atopic dermatitis. University of Minnesota Libraries Publishing 2021-09-22 /pmc/articles/PMC9401380/ /pubmed/36033108 http://dx.doi.org/10.24926/iip.v12i4.4329 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Langley, Paul C.
A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
title A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
title_full A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
title_fullStr A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
title_full_unstemmed A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
title_short A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
title_sort critical examination of simulation pricing and access recommendations for atopic dermatitis
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401380/
https://www.ncbi.nlm.nih.gov/pubmed/36033108
http://dx.doi.org/10.24926/iip.v12i4.4329
work_keys_str_mv AT langleypaulc acriticalexaminationofsimulationpricingandaccessrecommendationsforatopicdermatitis
AT langleypaulc criticalexaminationofsimulationpricingandaccessrecommendationsforatopicdermatitis